Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer ; A Randomized Phase 3 Trial with a Primary Pain Endpoint

Ethan M Basch, Mark Scholz, Johann S de Bono, Nicholas Vogelzang, Paul de Souza, Gavin Marx, Ulka Vaishampayan, Saby George, James K Schwarz, Emmanuel S Antonarakis, Joseph M O'Sullivan, Arash Rezazadeh Kalebasty, Kim N Chi, Robert Dreicer, Thomas E Hutson, Amylou C Dueck, Antonia V Bennett, Erica Dayan, Milan Mangeshkar, Jaymes HollandAaron L Weitzman, Howard I Scher

Research output: Contribution to journalArticlepeer-review

37 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer ; A Randomized Phase 3 Trial with a Primary Pain Endpoint'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science